A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

NCT01870843 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Escitalopram

Sponsor

Xian-Janssen Pharmaceutical Ltd.